Health technology assessment for the acute and preventive treatment of migraine: A position statement of the International Headache Society

The Clinical Trials Subcommittee of the International Headache Society presents the first Health Technology Assessment for the Acute Treatment of Migraine Attacks and Prevention of Migraine. Health technology assessments are systematic evaluations of the properties, effects, and consequences of healthcare technologies; this position statement is designed to inform decision makers about access to and reimbursement for medications and devices for the acute and preventive treatment of migraine. This position statement extends beyond the already available guidelines on randomized controlled trials for migraine to incorporate real-world evidence and a synthetic approach for considering multiple data sources and modelling methods when assessing the value of migraine treatments.

Automated summary

The Health Technology Assessment by the Clinical Trials Subcommittee of the International Headache Society aims to inform decision makers about access to and reimbursement for medications and devices for the acute and preventive treatment of migraine, incorporating real-world evidence and a synthetic approach for assessing the value of migraine treatments using multiple data sources and modelling methods.